Antisense therapy of cancer

Area of Science:

• Molecular Biology
• Cellular Biology
• Immunology

Background:

• Nuclear factor kappa B (NF-kappa B) is a transcription factor complex involved in regulating genes related to cell adhesion, cytokines, and growth factor receptors.
• NF-kappa B comprises p50 (NFKB1) and p65 (rel A) subunits, and its role in cell growth and disease processes like cancer and inflammation is significant.

Purpose of the Study:

• To investigate the role of NF-kappa B in cellular adhesion using antisense techniques.
• To evaluate the therapeutic potential of targeting NF-kappa B in disease models.

Main Methods:

• Utilized antisense phosphorothioate oligomers directed against the rel A subunit of NF-kappa B.
• Assessed the impact of these oligomers on cellular adhesion in vitro.
• Validated the efficacy of the oligomers in various in vivo disease models.

Main Results:

• Antisense oligomers targeting the rel A subunit of NF-kappa B unexpectedly caused a significant blockade of cellular adhesion.
• Demonstrated the in vivo efficacy of phosphorothioate oligomers in relevant disease models.
• The findings highlight a critical role for NF-kappa B in maintaining cellular adhesion.

Conclusions:

• NF-kappa B signaling is crucial for cellular adhesion.
• Antisense phosphorothioate oligomers targeting NF-kappa B show promise as a therapeutic strategy for diseases involving aberrant cell adhesion, such as cancer and inflammation.
• The study confirms the in vivo effectiveness of these oligomers.